Artificial intelligence in drug discovery and development
Open accessAbstract
Artificial intelligence-integrated drug discovery and development has accelerated the growth of the pharmaceutical sector, leading to a revolutionary change in the pharma industry. Here, we discuss areas of integration, tools, and techniques utilized in enforcing AI, ongoing challenges, and ways to overcome them.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AI is used for monitoring clinical trials, and data gathering and analysis from them.
“They are also used in monitoring clinical trials, and data gathering and analysis from them [30].”
From A Review of Trustworthy and Explainable Artificial Intelligence (XAI) (2023) · cites this paper as [30]
The 'AI in clinical trial design' section describes software monitoring medication intake during a Phase II trial. The 'AI in the lifecycle of pharmaceutical products' section says AI can manage generated clinical data, but our copy does not establish that AI gathers and analyzes data from clinical trials specifically. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measuredErrors by AI or the human involved in the creation of the AI could lead to loss of lives.
“Any errors by AI or the human involved in the creation of the AI, could lead to loss of lives [30], [33], [34].”
From A Review of Trustworthy and Explainable Artificial Intelligence (XAI) (2023) · cites this paper as [30]
The ‘Ongoing challenges in adopting AI’ section discusses data quality, inaccurate predictions, and the need for human intervention, but does not say that AI or human errors could cause loss of life. A further search for fatal errors, patient deaths, and related harms found no passage addressing that consequence. No page numbers were available in our copy. (LLM, conf=0.75)
Experimental — accuracy not yet measuredThe use of AI in medicinal chemistry has gained significant attention in recent years as a potential means of revolutionizing the pharmaceutical industry.
“The use of artificial intelligence (AI) in medicinal chemistry has gained significant attention in recent years as a potential means of revolutionizing the pharmaceutical industry [3].”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [3]
AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [3]
Integration of AI with traditional experimental methods can enhance the drug discovery process.
“However, the integration of AI with traditional experimental methods can also enhance the drug discovery process [3].”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
How artificial intelligence will change the future of marketing
Davenport, T., Guha, A., Grewal, D., & Bressgott, T. (2020) · Journal of the Academy of Marketing Science · doi:10.1007/s11747-019-00696-0 · Cited by 2,875 · see citing works
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536 · see citing works
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847 · see citing works
ARTIFICIAL INTELLIGENCE FOR THE REAL WORLD
Davenport, T. H., & Ronanki, R. (2023) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets42512 · Cited by 1,829 · see citing works
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Özkırımlı, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,728 · see citing works
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537 · see citing works
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,379 · see citing works
Artificial Intelligence and the Public Sector—Applications and Challenges
Wirtz, B. W., Weyerer, J. C., & Geyer, C. (2019) · International Journal of Public Administration · doi:10.1080/01900692.2018.1498103 · Cited by 1,341 · see citing works
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · see citing works
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,045 · see citing works
Fogel, D. B. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.001 · Cited by 1,035 · see citing works
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018 · see citing works
Artificial intelligence in medicine
Ramesh, A., Kambhampati, C., Monson, J. Q., & Drew, P. J. (2004) · Annals of The Royal College of Surgeons of England · doi:10.1308/147870804290 · Cited by 1,008 · see citing works
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 880 · see citing works
Syam, N., & Sharma, A. (2018) · Industrial Marketing Management · doi:10.1016/j.indmarman.2017.12.019 · Cited by 852 · see citing works
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.010 · Cited by 760 · see citing works
(1999) · CRC Press eBooks · doi:10.1201/9781420049176 · Cited by 717 · see citing works
Computer-Assisted Design of Complex Organic Syntheses
Corey, E. J., & Wipke, W. T. (1969) · Science · doi:10.1126/science.166.3902.178 · Cited by 688 · see citing works
Artificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672 · see citing works
Advancing drug discovery via artificial intelligence
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654 · see citing works
Organic synthesis in a modular robotic system driven by a chemical programming language
Steiner, S., Wolf, J. B., Glatzel, S., Andreou, A., Granda, J. M., Keenan, G., Hinkley, T., Aragón-Camarasa, G., Kitson, P. J., Angelone, D., et al. (2018) · Science · doi:10.1126/science.aav2211 · Cited by 630 · see citing works
Lusci, A., Pollastri, G., & Baldi, P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400187y · Cited by 557 · see citing works
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546 · cited 1× · see citing works
“Even then, nine out of ten therapeutic molecules fail Phase II clinical trials and regulatory approval [31,32].”
BackgroundKarimi, M., Wu, D. J., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536 · see citing works
Polypharmacology: drug discovery for the future
Reddy, A. S., & Zhang, S. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.74 · Cited by 486 · see citing works
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455 · see citing works
The Future of Pharmaceutical Manufacturing Sciences
Rantanen, J., & Khinast, J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24594 · Cited by 452 · see citing works
Recurrent neural networks: design and applications
Stoianov, I. (1999) · Cited by 442 · see citing works
Micro‐/Nanorobots at Work in Active Drug Delivery
Luo, M., Feng, Y., Wang, T., & Guan, J. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201706100 · Cited by 442 · see citing works
Yu, H., Chen, M., Xu, X. J., Li, Y., Zhao, H., Fang, Y., Li, X., Zhou, W., Wang, W., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037608 · Cited by 422 · see citing works
Boosting docking-based virtual screening with deep learning.
Pereira, J. C., Caffarena, E. R., & dos Santos, C. N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00355 · Cited by 395 · see citing works
Artificial Intelligence in Drug Design
Heßler, G., & Baringhaus, K. H. (2018) · Molecules · doi:10.3390/molecules23102520 · Cited by 387 · see citing works
Artificial Intelligence for Drug Toxicity and Safety
Basile, A. O., Yahi, A., & Tatonetti, N. P. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.005 · Cited by 385 · see citing works
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 381 · see citing works
<i>De Novo</i> Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373 · see citing works
End-to-End Differentiable Learning of Protein Structure
AlQuraishi, M. (2019) · Cell Systems · doi:10.1016/j.cels.2019.03.006 · Cited by 371 · see citing works
Singh, J., Flaherty, K. E., Sohi, R. S., Deeter‐Schmelz, D. R., Habel, J., Meunier‐FitzHugh, K. L., Malshe, A., Mullins, R. R., & Onyemah, V. (2019) · Journal of Personal Selling and Sales Management · doi:10.1080/08853134.2018.1557525 · Cited by 366 · see citing works
Target identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357 · see citing works
Klucznik, T., Mikulak-Klucznik, B., McCormack, M. P., Lima, H. M., Szymkuć, S., Bhowmick, M., Molga, K., Zhou, Y., Rickershauser, L., Gajewska, E. P., et al. (2018) · Chem · doi:10.1016/j.chempr.2018.02.002 · Cited by 353 · see citing works
Process control and scale-up of pharmaceutical wet granulation processes: a review
Faure, A., York, P., & Rowe, R. C. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00184-9 · Cited by 316 · see citing works
A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials
Gayvert, K. M., Madhukar, N. S., & Elemento, O. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.023 · Cited by 310 · see citing works
The significance of artificial intelligence in drug delivery system design
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.001 · Cited by 307 · see citing works
A review of computational drug repurposing
Park, K. (2019) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2019.27.2.59 · Cited by 303 · see citing works
Process Modeling in the Pharmaceutical Industry using the Discrete Element Method
Ketterhagen, W. R., Ende, M. T. A., & Hancock, B. C. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21466 · Cited by 250 · see citing works
Interpretable Drug Target Prediction Using Deep Neural Representation
Gao, K. Y., Fokoue, A., Luo, H., Iyengar, A., Dey, S., & Zhang, P. (2018) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/468 · Cited by 248 · see citing works
Artificial Intelligence Approaches for Rational Drug Design and Discovery
Duch, W., Swaminathan, K., & Meller, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765954 · Cited by 245 · see citing works
The Artificial Life Route to Artificial Intelligence
Steels, L., & Brooks, R. A. (2018) · Routledge eBooks · doi:10.4324/9781351001885 · Cited by 241 · see citing works
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227 · see citing works
CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence
Blasiak, A., Khong, J., & Kee, T. W. (2019) · SLAS TECHNOLOGY · doi:10.1177/2472630319890316 · Cited by 225 · see citing works
Artificial intelligence approach fighting COVID-19 with repurposing drugs
Ke, Y., Peng, T.-T., Yeh, T., Huang, W.-Z., Chang, S.-E., Wu, S.-H., Hung, H., Hsu, T., Lee, S., Song, J.-S., et al. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.001 · Cited by 222 · see citing works
Xiao, X., Min, J., Lin, W., Liu, Z., Cheng, X., & Chou, K. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.998710 · Cited by 218 · see citing works
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212 · see citing works
Positioning strategies in business markets
Kalafatis, S. P., Tsogas, M. H., & Blankson, C. (2000) · Journal of Business and Industrial Marketing · doi:10.1108/08858620010349501 · Cited by 201 · see citing works
Zang, Q., Mansouri, K., Williams, A. J., Judson, R., Allen, D., Casey, W., & Kleinstreuer, N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00625 · Cited by 199 · see citing works
Global perspectives on the ecology of human-machine systems
Lee, A. T. (1996) · Journal of the American Society for Information Science · doi:10.1002/(sici)1097-4571(199606)47:6 · Cited by 194 · see citing works
Boosting compound-protein interaction prediction by deep learning
Tian, K., Shao, M., Wang, Y., Guan, J., & Zhou, S. (2016) · Methods · doi:10.1016/j.ymeth.2016.06.024 · Cited by 183 · see citing works
Artificial Intelligence in Drug Discovery
Sellwood, M. A., Ahmed, M., Segler, M., & Brown, N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0212 · Cited by 174 · see citing works
Automated De Novo Drug Design: Are We Nearly There Yet?
Schneider, G., & Clark, D. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814681 · Cited by 168 · see citing works
Brand Positioning Strategy Using Search Engine Marketing1
Dou, Lim, K. H., Su, Zhou, N., & , C. (2010) · MIS Quarterly · doi:10.2307/20721427 · Cited by 161 · see citing works
A Study on the Application and Use of Artificial Intelligence to Support Drug Development
Lamberti, M. J., Wilkinson, M., Donzanti, B. A., Wohlhieter, G. E., Parikh, S., Wilkins, R. G., & Getz, K. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.05.018 · Cited by 160 · see citing works
Artificial intelligence in nanomedicine
Ho, D., Wang, P., & Kee, T. W. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00233a · Cited by 150 · see citing works
Comparison Study of Computational Prediction Tools for Drug-Target Binding Affinities
Thafar, M. A., Raies, A. B., Albaradei, S., Essack, M., & Bajić, V. B. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00782 · Cited by 146 · see citing works
Deep Learning in Drug Discovery and Medicine; Scratching the Surface
Dana, D., Gadhiya, S., Surin, L. S., Li, D., Naaz, F., Ali, Q., Paka, L., Yamin, M., Narayan, M., Goldberg, I. D., et al. (2018) · Molecules · doi:10.3390/molecules23092384 · Cited by 141 · see citing works
Koromina, M., Pandi, M.-T., & Patrinos, G. P. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0151 · Cited by 140 · see citing works
Artificial intelligence in nanotechnology
Sacha, G. M., & Varona, P. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/45/452002 · Cited by 134 · see citing works
Li, X., Xu, Y., Cui, H. S., Huang, T., Wang, D., Lian, B., Li, W., Qin, G., Chen, L., & Xie, L. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.05.008 · Cited by 127 · see citing works
Using artificial intelligence methods to speed up drug discovery
Álvarez-Machancoses, Ó., & Fernández‐Martínez, J. L. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1621284 · Cited by 127 · see citing works
Artificial intelligence in drug combination therapy
Tsigelny, I. F. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby004 · Cited by 120 · see citing works
Future trends in process automation
Jämsä‐Jounela, S. (2007) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2007.08.003 · Cited by 118 · see citing works
Brand positioning strategy using search engine marketing
Dou, W., Lim, K. H., Su, C., Zhou, N., & Cui, N. (2010) · MIS Quarterly · doi:10.5555/2017458.2017462 · Cited by 115 · see citing works
An intelligent market segmentation system using k-means and particle swarm optimization
Chiu, C.-Y., Chen, Y.-F., Kuo, I.-T., et al. (2008) · Expert Systems with Applications · doi:10.1016/j.eswa.2008.05.029 · Cited by 114 · see citing works
Chematica: A Story of Computer Code That Started to Think like a Chemist
Grzybowski, B. A., Szymkuć, S., Gajewska, E. P., Molga, K., Dittwald, P., Wołos, A., & Klucznik, T. (2018) · Chem · doi:10.1016/j.chempr.2018.02.024 · Cited by 114 · cited 1× · see citing works
“Grzybowski et al. developed the Chematica program [74], now renamed Synthia, which has the ability to encode a set of rules into the machine and propose possible synthesizing routes for eight medicinally essential targets.”
Computational modeling for formulation design
Mehta, C. H., Narayan, R., & Nayak, U. Y. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.018 · Cited by 114 · see citing works
Intelligent systems in manufacturing: current developments and future prospects
Meziane, F., Vadera, S., Kobbacy, K. A. H., et al. (2000) · Integrated Manufacturing Systems · doi:10.1108/09576060010326221 · Cited by 113 · see citing works
PADME: A Deep Learning-based Framework for Drug-Target Interaction PredictionPreprint
Feng, Q., Dueva, E., Cherkasov, A. R., & Ester, M. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1807.09741 · Cited by 107 · see citing works
FUTURE TRENDS IN PROCESS AUTOMATION
Jämsä‐Jounela, S. (2007) · IFAC Proceedings Volumes · doi:10.3182/20070213-3-cu-2913.00003 · Cited by 102 · see citing works
Search Algorithms as a Framework for the Optimization of Drug Combinations
Calzolari, D., Bruschi, S., Coquin, L., Schofield, J., Feala, J., Reed, J. C., McCulloch, A. D., & Paternostro, G. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000249 · Cited by 101 · see citing works
Baronzio, G., Parmar, G., & Baronzio, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00165 · Cited by 100 · see citing works
The potential application of artificial intelligence in transport
Miles, J. C., & Walker, A. J. (2006) · IEE Proceedings - Intelligent Transport Systems · doi:10.1049/ip-its:20060014 · Cited by 96 · see citing works
Deep learning with feature embedding for compound-protein interaction predictionPreprint
Wan, F., & Zeng, J. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/086033 · Cited by 93 · see citing works
Aksu, B., Paradkar, A. R., de Matas, M., et al. (2012) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2012.705294 · Cited by 91 · see citing works
An integrative machine learning approach for prediction of toxicity-related drug safety
Lysenko, A., Sharma, A., Boroevich, K. A., & Tsunoda, T. (2018) · Life Science Alliance · doi:10.26508/lsa.201800098 · Cited by 88 · see citing works
Tox_(R)CNN: Deep learning-based nuclei profiling tool for drug toxicity screening
Jiménez‐Carretero, D., Abrishami, V., Fernández-de-Manúel, L., Palacios, I., Quílez-Álvarez, A., Díez-Sánchez, A., del Pozo, M. Á., & Montoya, M. C. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006238 · Cited by 84 · see citing works
Wang, F., Liu, D., Wang, H., et al. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200264h · Cited by 80 · see citing works
Prediction of Human Intestinal Absorption of Compounds Using Artificial Intelligence Techniques
Kumar, R., Sharma, A., Siddiqui, M. H., & Tiwari, R. (2017) · Current Drug Discovery Technologies · doi:10.2174/1570163814666170404160911 · Cited by 79 · see citing works
Controlled drug release by a nanorobot
Fu, J., & Yan, H. (2012) · Nature Biotechnology · doi:10.1038/nbt.2206 · Cited by 78 · see citing works
The Future of Pharmaceutical Product Development and Research
(2020) · Elsevier eBooks · doi:10.1016/c2017-0-01075-3 · Cited by 78 · see citing works
Computational Tools for Polypharmacology and Repurposing
Achenbach, J., Tiikkainen, P., Franke, L., & Proschak, E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.62 · Cited by 77 · see citing works
Innovation and Marketing in the Pharmaceutical Industry
Ding, M., Eliashberg, J., & Stremersch, S. (2013) · International series in quantitative marketing · doi:10.1007/978-1-4614-7801-0 · Cited by 77 · see citing works
Brand positioning strategies for industrial firms providing customer solutions
Jalkala, A. M., & Keränen, J. (2014) · Journal of Business and Industrial Marketing · doi:10.1108/jbim-10-2011-0138 · Cited by 76 · see citing works
Artificial Neural Network for Drug Design, Delivery and Disposition
(2016) · Elsevier eBooks · doi:10.1016/c2014-0-00253-5 · Cited by 70 · see citing works
Neural networks for cost estimation of shell and tube heat exchangers
Durán, O., Rodríguez, N., & Consalter, L. A. (2008) · Expert Systems with Applications · doi:10.1016/j.eswa.2008.09.014 · Cited by 69 · see citing works
Wang, Y., Guo, Y., Kuang, Q., Pu, X., Ji, Y., Zhang, Z., & Li, M. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9827-y · Cited by 69 · see citing works
Toward intelligent decision support for pharmaceutical product development
Zhao, C., Jain, A., Hailemariam, L., et al. (2006) · Journal of Pharmaceutical Innovation · doi:10.1007/bf02784878 · Cited by 66 · see citing works
A Qualitative Research on Marketing and Sales in the Artificial Intelligence Age
Yang, Y., & Siau, K. L. (2018) · Singapore Management University Institutional Knowledge (InK) (Singapore Management University) · Cited by 63 · see citing works
Firth, N. C., Atrash, B., Brown, N., & Blagg, J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00073 · Cited by 61 · see citing works
Artificial intelligence in the pharmaceutical sector: current scene and future prospect
Kalyane, D., Sanap, G., Paul, D., Shenoy, S., Anup, N., Polaka, S., Tambe, V., & Tekade, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814455-8.00003-7 · Cited by 61 · see citing works
Self-citationMahmud, S., Chen, W., Jahan, H., Liu, Y., Sujan, N. I., & Ahmad, S. (2019) · IEEE Access · doi:10.1109/access.2019.2910277 · Cited by 59 · see citing works
Artificial Intelligence and Collusion
Beneke, F., & Mackenrodt, M.-O. (2018) · GRURRR. Gewerblicher Rechtsschutz und Urheberrecht, Rechtsprechungs-Report/GRUR-DVD/GRUR-CD/IIC/Gewerblicher Rechtsschutz und Urheberrecht/Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil · doi:10.1007/s40319-018-00773-x · Cited by 55 · see citing works
On the Use of Artificial Neural Networks to Monitor a Pharmaceutical Freeze-Drying Process
Drăgoi, E.-N., Curteanu, S., & Fissore, D. (2013) · Drying Technology · doi:10.1080/07373937.2012.718308 · Cited by 51 · see citing works
Application of a Recurrent Neural Network to Prediction of Drug Dissolution Profiles
Goh, W. Y., Lim, C. P., Peh, K. K., & Subari, K. (2002) · Neural Computing and Applications · doi:10.1007/s005210200003 · Cited by 50 · see citing works
Buscema, M., Massini, G., Breda, M., et al. (2018) · Studies in systems, decision and control · doi:10.1007/978-3-319-75049-1_2 · Cited by 49 · see citing works
Artificial Intelligence and Related Technologies Enabled Nanomedicine for Advanced Cancer Treatment
Wilson, B., & Geetha, K. M. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0366 · Cited by 48 · see citing works
KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules
Li, Z. S., Li, X., Liu, X., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz519 · Cited by 47 · see citing works
Integrating Artificial and Human Intelligence into Tablet Production Process
Gams, M., Horvat, M., Ožek, M., et al. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0174-z · Cited by 46 · see citing works
A grand product design model for crystallization solvent design
Chai, S., Liu, Q., Liang, X., et al. (2020) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2020.106764 · Cited by 45 · see citing works
Chen, W., Desai, D., Good, D., et al. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0423-9 · Cited by 43 · see citing works
Mason, D. J., Eastman, R. T., Lewis, R. P. I., Stott, I. P., Guha, R., & Bender, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01096 · Cited by 43 · see citing works
COMPARISON OF ARTIFICIAL INTELLIGENCE METHODS FOR MODELING PHARMACEUTICAL QSARS
King, R. D., Hirst, J. D., & Sternberg, M. J. E. (1995) · Applied Artificial Intelligence · doi:10.1080/08839519508945474 · Cited by 39 · see citing works
Automated De Novo Drug Design: Are We Nearly There Yet?
Schneider, G., & Clark, D. E. (2019) · Angewandte Chemie · doi:10.1002/ange.201814681 · Cited by 37 · see citing works
Cellular Neural Networks: Analysis, Design and Optimization
Hänggi, M., & Moschytz, G. S. (2000) · Medical Entomology and Zoology · Cited by 35 · see citing works
In silico de novo design of novel NNRTIs: a bio-molecular modelling approach
Jain, N., Gupta, S., Sapre, N., & Sapre, N. S. (2015) · RSC Advances · doi:10.1039/c4ra15478a · Cited by 35 · see citing works
Wilson, W. I., Peng, Y. F., & Augsburger, L. L. (2005) · AAPS PharmSciTech · doi:10.1208/pt060356 · Cited by 35 · see citing works
Estimation of Acid Dissociation Constants Using Graph Kernels
Rupp, M., Körner, R., & Tetko, I. V. (2010) · Molecular Informatics · doi:10.1002/minf.201000072 · Cited by 33 · see citing works
AI protein-folding algorithms solve structures faster than ever
Hutson, M. (2019) · Nature · doi:10.1038/d41586-019-01357-6 · Cited by 33 · see citing works
Artificial Intelligence Tools for Scaling Up of High Shear Wet Granulation Process
Landín, M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.022 · Cited by 32 · see citing works
How Artificial Intelligence and Machine Learning Can Impact Market Design
Milgrom, P., & Tadelis, S. (2019) · University of Chicago Press eBooks · doi:10.7208/chicago/9780226613475.003.0023 · Cited by 30 · see citing works
Venkatesan, R., & Li, B. (2017) · CRC Press eBooks · doi:10.4324/9781315154282-3 · Cited by 27 · see citing works
A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development
Guo, M., Kalra, G., Wilson, W. I., et al. (2002) · Pharmaceutical technology · Cited by 24 · see citing works
Foundations of Artificial Neural Networks
Bielecki, A. (2018) · Studies in computational intelligence · doi:10.1007/978-3-319-90140-4_3 · Cited by 24 · see citing works
ANN in Pharmaceutical Product and Process Development
Das, M. K., & Chakraborty, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801559-9.00014-4 · Cited by 21 · see citing works
Intelligent Quality Management Using Knowledge Discovery in Databases
Wang, X. (2009) · doi:10.1109/cise.2009.5364999 · Cited by 19 · see citing works
Models of Neurons and Perceptrons: Selected Problems and Challenges
Bielecki, A. (2018) · Studies in computational intelligence · doi:10.1007/978-3-319-90140-4 · Cited by 18 · see citing works
A Decision Model for Pharmaceutical Marketing and a Case Study in Turkey
Toker, D., Tozan, H., & Vayvai, O. (2013) · Economic Research-Ekonomska Istraživanja · doi:10.1080/1331677x.2013.11517592 · Cited by 16 · see citing works
Artificial Intelligence in Prediction of Secondary Protein Structure Using CB513 Database.
Avdagić, Z., Purisevic, E., Omanović, S., et al. (2009) · PubMed · Cited by 12 · see citing works
A LITERATURE REVIEW OF FACTORS AFFECTING PRICE AND COMPETITION IN THE GLOBAL PHARMACEUTICAL MARKET
Park, Y., Goto, D., Yang, K., et al. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.816 · Cited by 9 · see citing works
Management and evolution of the European Union member states in the Big Data era
Anghelache, C., & Pellat, G. (2020) · Sciendo eBooks · doi:10.2478/9788395720475 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [52]Basile A.O. Artificial intelligence for drug toxicity and safety Trends Pharmacol. Sci. 40 2019 624 635 31383376 PMC6710127
Cited by
Sorted by citations
A Review of the Role of Artificial Intelligence in Healthcare
Al Kuwaiti, A., Nazer, K., Al-Reedy, A., Al-Shehri, S., Al-Muhanna, A., Subbarayalu, A. V., Al Muhanna, D., & Al-Muhanna, F. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060951 · Cited by 915 · see citing works
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690 · see citing works
Generative AI in medical practice: in-depth exploration of privacy and security challenges
Chen, Y., & Esmaeilzadeh, P. (2024) · Journal of Medical Internet Research · doi:10.2196/53008 · Cited by 353 · see citing works
A Review of Trustworthy and Explainable Artificial Intelligence (XAI)
Chamola, V., Hassija, V., Sulthana, A. R., Ghosh, D., Dhingra, D., & Sikdar, B. (2023) · IEEE Access · doi:10.1109/access.2023.3294569 · Cited by 352 · see citing works
Blockchain and Artificial Intelligence Technology in E-Health
Tagde, P., Tagde, S., Bhattacharya, T., Tagde, P., Chopra, H., Akter, R., Kaushik, D., & Rahman, M. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16223-0 · Cited by 281 · see citing works
Yelne, S., Chaudhary, M., Dod, K., Sayyad, A., & Sharma, R. (2023) · Cureus · doi:10.7759/cureus.49252 · Cited by 190 · see citing works
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171 · see citing works
Tolentino, R., Baradaran, A., Gore, G., Pluye, P., & Abbasgholizadeh-Rahimi, S. (2024) · JMIR Medical Education · doi:10.2196/54793 · Cited by 165 · see citing works
Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00352 · Cited by 132 · see citing works
Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients
Busch, F., Hoffmann, L., Xu, L., Zhang, L. J., Hu, B., García-Juárez, I., Toapanta-Yanchapaxi, L. N., Gorelik, N., Gorelik, V., Rodriguez-Granillo, G. A., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.14452 · Cited by 124 · see citing works
Explainable artificial intelligence for drug discovery and development: a comprehensive survey
Alizadehsani, R., Oyelere, S. S., Hussain, S., Jagatheesaperumal, S. K., Calixto, R. R., Rahouti, M., Roshanzamir, M., & De Albuquerque, V. H. C. (2024) · IEEE Access · doi:10.1109/access.2024.3373195 · Cited by 124 · see citing works
Onciul, R., Tataru, C.-I., Dumitru, A. V., Crivoi, C., Serban, M., Covache-Busuioc, R.-A., Radoi, M. P., & Toader, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020550 · Cited by 113 · see citing works
Toward Trustworthy Artificial Intelligence (TAI) in the Context of Explainability and Robustness
chander, B., John, C., Warrier, L., & Gopalakrishnan, K. (2025) · ACM Computing Surveys · doi:10.1145/3675392 · Cited by 108 · see citing works
Udegbe, F. C., Ebulue, O. R., Ebulue, C. C., & Ekesiobi, C. S. (2024) · International Medical Science Research Journal · doi:10.51594/imsrj.v4i4.1052 · Cited by 103 · see citing works
Artificial intelligence & clinical nutrition: What the future might have in store
Bond, A., Mccay, K., & Lal, S. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.07.082 · Cited by 79 · see citing works
Busch, F., Hoffmann, L., Truhn, D., Palaian, S., Alomar, M., Shpati, K., Makowski, M. R., Bressem, K. K., & Adams, L. C. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15911 · Cited by 80 · see citing works
Hasan, H. E., Jaber, D., Al Tabbah, S., Lawand, N., Habib, H. A., & Farahat, N. M. (2024) · PLOS ONE · doi:10.1371/journal.pone.0296884 · Cited by 76 · see citing works
Can Artificial Intelligence Replace the Unique Nursing Role?
Mohanasundari, S. K., Kalpana, M., Madhusudhan, U., Vasanthkumar, K., B, R., Singh, R., Vashishtha, N., & Bhatia, V. (2023) · Cureus · doi:10.7759/cureus.51150 · Cited by 71 · see citing works
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61 · see citing works
Artificial intelligence for dementia drug discovery and trials optimization
Doherty, T., Yao, Z., Khleifat, A. A. L., Tantiangco, H., Tamburin, S., Albertyn, C., Thakur, L., Llewellyn, D. J., Oxtoby, N. P., Lourida, I., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13428 · Cited by 48 · see citing works
Henzler, D., Schmidt, S., Koçar, A., Herdegen, S., Lindinger, G. L., Maris, M. T., Bak, M. A. R., Willems, D. L., Tan, H. L., Lauerer, M., et al. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12664-2 · Cited by 54 · see citing works
“Furthermore, AI can also be applied to medical research and drug development (e.g., automated manufacturing), health systems management and planning (e.g., resource allocation), and public health activities (e.g., health promotion, surveillance, and outbreak response) [5, 8, 9].”
(2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-023-00624-2 · Cited by 42 · see citing works
Advancing health care via artificial intelligence: From concept to clinic
Sandeep Ganesh, G., Kolusu, A. S., Prasad, K., Samudrala, P. K., & Nemmani, K. V. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175320 · Cited by 43 · see citing works
A new paradigm for applying deep learning to protein–ligand interaction prediction
Wang, Z., Wang, S., Li, Y., Guo, J., Wei, Y., Mu, Y., Zheng, L., & Li, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae145 · Cited by 41 · see citing works
Accelerating Parkinson’s Disease drug development with federated learning approaches
Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., et al. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00837-5 · Cited by 21 · see citing works
A Review on the Integration of Artificial Intelligence in Healthcare
Pargaien, A. V., Pargaien, S., Nawaz, A., & Kumar, T. (2024) · 2024 5th International Conference on Electronics and Sustainable Communication Systems (ICESC) · doi:10.1109/icesc60852.2024.10689737 · Cited by 4 · see citing works
- Authors
- Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K.
- Affiliations
- Government of India (IN)
- Corresponding author
- Tekade, Rakesh K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 26
- Issue
- 1
- Pages
- 80-93
- ISSN
- 1359-6446 (ISSN-L)
- PMC
- PMC7577280
- OpenAlex
- W3094492244
- Cited by
- 1,695
- References
- 129
- Citations by year
- 2026: 308 · 2025: 385 · 2024: 479 · 2023: 278 · 2022: 159 · 2021: 83 · 2020: 2
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India
- Science and Engineering Research Board
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
- Keywords
- artificial intelligence, drug discovery, drug development, pharmaceutical industry, AI adoption barriers
- MeSH terms
- Pharmaceutical Research, Artificial Intelligence, Humans, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review